Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer - eBioMedicine
Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
Combining CRP and CA19-9 in a novel prognostic score in pancreatic ductal adenocarcinoma | Scientific Reports
extreme High levels of ca19-9 associated with adenocarcinoma of the lung
CA19-9/Sialyl Lewisa (GI Tumor Marker) Ab-1 Mouse Monoclonal Antibody, | Fisher Scientific
Preoperative serum CA19-9 should be routinely measured in the colorectal patients with preoperative normal serum CEA: a multicenter retrospective cohort study | BMC Cancer | Full Text
CA-19-9
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - Clinical Gastroenterology and Hepatology
CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer -
Performance of triple-marker panel vs. CA19-9 | Download Table
CA19-9 is a significant prognostic marker of patients with stage III gastric cancer - European Journal of Surgical Oncology
Evaluation of CEA, CA19-9, CRP and leucocyte count as prognostic marker... | Download Scientific Diagram
Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
58 Ca19 9 Images, Stock Photos & Vectors | Shutterstock
Blood Sample Ca199 Test Tumor Marker Stock Photo 1079580113 | Shutterstock
Elevation of CA19-9 and CEA is associated with a poor prognosis in patients with resectable gallbladder carcinoma - HPB
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice | Science
CA19-9 Level to Serum γ-Glutamyltransferase as a Potential Progn | CMAR
CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer | BMC Cancer | Full Text
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection - Gastroenterology
